Breakthrough pill tested to stop yeast infections from coming back

NCT ID NCT03561701

First seen Feb 17, 2026 · Last updated Apr 12, 2026 · Updated 4 times

Summary

This study tested whether a new oral medication called oteseconazole could safely prevent recurrent yeast infections in women. Over 400 women who typically had at least three infections a year were randomly assigned to take either the new drug or a placebo pill for 12 weeks, then followed for nearly a year to see if infections returned. The main goal was to see if the medication could significantly reduce the number of women experiencing another painful infection during that time.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECURRENT VULVOVAGINAL CANDIDIASIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • 31204

    Homestead, Florida, 33030, United States

  • 31215

    Phoenix, Arizona, 85032, United States

  • 31217

    Los Angeles, California, 90057, United States

  • 31218

    Jackson, Tennessee, 38305, United States

  • 31222

    Englewood, Ohio, 45322, United States

  • 31223

    Winston-Salem, North Carolina, 27103, United States

  • 31227

    Little Rock, Arkansas, 72212, United States

  • 31229

    Columbus, Ohio, 43231, United States

  • 31232

    Frisco, Texas, 75035, United States

  • 31233

    North Bay Village, Florida, 33141, United States

  • 31240

    Hartford, Connecticut, 06105, United States

  • 31244

    Columbus, Ohio, 43213, United States

  • 31245

    Hagerstown, Maryland, 21740, United States

  • 31255

    Wichita, Kansas, 67226, United States

Conditions

Explore the condition pages connected to this study.